Summary of significant treatment × time effect. by Wensheng Xiao (16557866)

Summary of significant single-arm time effect. by Wensheng Xiao (16557866)

Lymphocytes decreased in mouse pneumonia model. by Qi Xu (134661)

Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means. by Mohammad Bakhtiari (11838264)

Deletion of C3 and C3aR reversed <i>S. aureus</i>-induced decrease in synapse density and increase in microglial phagocytosis of synapses. by Haifang Zhang (314544)

Average mean decrease Gini across 100 partitions for the top 10 most important variables for binary mixed model and random forest. by Helal El-Zaatari (20442243)

AdMSC-EVs enhanced colony formation and migration of LECs and decreased proliferation. by Xiaoqin Li (1399105)

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

miRNA 221 improved left ventricular contractile function in MIRI mice. by Hongyu Li (1332669)

Mean KAP scores and standard deviation at different assessment times. by Chikondi Maluwa (20660522)

Subjects:

The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

Subjects:

Decreased synthesis of VCAM-1, tubulin and dynein proteins in the heart of mice stimulated with EVs (green) or ICs (blue). by Alberto Cornet-Gomez (10676133)

“…The values represent the mean ± SEM, with significance set at p < 0.05 (*).…”

The mean and standard deviation of outcome measures. by Soheila Qanbari (20455173)

Subjects:

Average days (mean) to heal a wound in 2022 and 2023. by Heba Tallah Mohammed (2822432)

Subjects:

Starvation improves locomotory capacity and decreases the number of α-synuclein-YFP aggregates of transgenic <i>C. elegans</i> through LMP-1 dependent mechanism. by María Gallardo-Campos (22170919)

Mean Values and Standard Deviations (Mean [±SD]) of Clinical Parameters: periodontal probing depth (PPD), clinical attachment level (CAL), bleeding on probing (BOP), and plaque ind... by Iva Milinkovic (22331710)

Subjects:

Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Study selection criteria. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Subjects:

Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

Subjects: